ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Neurology

Top Neurology Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
YUCHUN HAN M.D. & PH.D.

Neurology

11,616

$1.13M

833
181 are 65+

51%
patients receiving schedule two controlled substances

Avg: 2%

47%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$97
Average prescription price

Avg: $228

DONALD WHEATLEY MD

Neurology

7,000

$899K

606
301 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$128
Average prescription price

Avg: $228

MATTHEW KODSI MD PHD

Neurology

6,786

$2.14M

658
529 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

50%
prescriptions for brand name drugs

Avg: 24%

$316
Average prescription price

Avg: $228

TIMOTHY HIMEL

Neurology

6,515

$596K

289
153 are 65+

18%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$91
Average prescription price

Avg: $228

RAYMOND CAPPS MD

Neurology

5,904

$1.22M

506
312 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$207
Average prescription price

Avg: $228

MICHAEL BRUEGGEMAN M.D.

Neurology

5,696

$1.17M

607
370 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$206
Average prescription price

Avg: $228

ROBERT MACDONALD M.D.

Neurology

5,653

$754K

720
434 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $228

THOMAS HEAD M.D.

Neurology

5,542

$550K

609
449 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $228

DANIEL DONOVAN MD

Neurology

5,371

$1.28M

329
100 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$239
Average prescription price

Avg: $228

RAVI CHANDER MD

Neurology

5,252

$826K

505
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$157
Average prescription price

Avg: $228

JOHN DOUGHERTY M.D.

Neurology

5,237

$862K

735
615 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$165
Average prescription price

Avg: $228

OTAKAR KRCAL MD

Neurology

5,175

$916K

516
273 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$177
Average prescription price

Avg: $228

DOUGLAS WRIGHT M.D.

Neurology

5,108

$1.38M

450
281 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$271
Average prescription price

Avg: $228

EUGENE LAFRANCHISE M.D.

Neurology

5,059

$751K

612
500 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $228

ADELE ACKELL MD

Neurology

4,997

$1.16M

380
257 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$232
Average prescription price

Avg: $228

DAVID RANKINE MD

Neurology

4,882

$1.31M

383
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$269
Average prescription price

Avg: $228

SAMIR AL-KABBANI MD

Neurology

4,724

$2.08M

561
130 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 24%

$440
Average prescription price

Avg: $228

RANDY GAW MD

Neurology

4,582

$910K

513
419 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$199
Average prescription price

Avg: $228

STEPHEN KIMBROUGH MD

Neurology

4,463

$2.09M

314
158 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$468
Average prescription price

Avg: $228

MICHAEL DESHAZO MD

Neurology

4,409

$953K

452
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$216
Average prescription price

Avg: $228

SHIVA NATARAJAN

Neurology

4,355

$758K

497
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$174
Average prescription price

Avg: $228

MICHELLE BREWER M.D.

Neurology

4,339

$927K

510
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$214
Average prescription price

Avg: $228

RONALD WILSON MD

Neurology

4,263

$518K

328
210 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $228

SHARON FARBER MD

Neurology

4,228

$1.44M

367
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$340
Average prescription price

Avg: $228

SALMAN SAEED M.D.

Neurology

4,101

$1.27M

548
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$309
Average prescription price

Avg: $228

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank